Supreme Court Deadlocks, Rezulin Lawsuits Proceed
WASHINGTON (CN) - The U.S. Supreme Court deadlocked in a dispute stemming from several lawsuits by people who claimed they were harmed by Rezulin, a diabetes drug manufactured by Warner-Lambert Co. With the chief justice not participating, the 4-4 split vote left intact the 2nd Circuit's ruling allowing the case to proceed.